New family of promising, Selective Silver-based Anti-cancer Drugs discovered

A family of economical silver-based complexes show very promising results against a number of human cancers in laboratory tests, with very low toxicity in rat studies and minimal effects on healthy cells. One of these, UJ3, is as effective as the industry-standard drug Cisplatin in killing cancer cells in laboratory tests done on human esophageal cancer, breast cancer and melanoma. This matrix of light microscope images show a comparison of human esophageal cancer cells treated with UJ3 and Cisplatin. Credit: Dr Zelinda Engelbrecht, University of Johannesburg

A family of economical silver-based complexes show very promising results against a number of human cancers in laboratory tests, with very low toxicity in rat studies and minimal effects on healthy cells. One of these, UJ3, is as effective as the industry-standard drug Cisplatin in killing cancer cells in laboratory tests done on human esophageal cancer, breast cancer and melanoma. This matrix of light microscope images show a comparison of human esophageal cancer cells treated with UJ3 and Cisplatin. Credit: Dr Zelinda Engelbrecht, University of Johannesburg

A new family of potential silver-based anti-cancer drugs has been discovered by researchers in South Africa...

Read More

Calorie Restriction Trial in Humans Suggests Benefits for Age-Related Disease

This graphical abstract depicts the effects of a 2-year calorie restriction (CR) trial in healthy, non-obese humans, which found evidence that prolonged CR enhances resting energy efficiency, resulting in decreased oxidative damage to tissues and organs. Credit: Redman et al./Cell Metabolism

This graphical abstract depicts the effects of a 2-year calorie restriction (CR) trial in healthy, non-obese humans, which found evidence that prolonged CR enhances resting energy efficiency, resulting in decreased oxidative damage to tissues and organs. Credit: Redman et al./Cell Metabolism

One of the first studies to explore the effects of calorie restriction on humans showed that cutting caloric intake by 15% for 2 years slowed aging and metabolism and protected against age-related disease. The study, which will appear March 22 in the journal Cell Metabolism, found that calorie restriction decreased systemic oxidative stress, which has been tied to age-related neurological conditions such as Alzheimer’s and Parkinson’s diseases, as well as cancer, diabetes, and others.

“Restricting calo...

Read More

Kepler Solves Mystery of Fast and Furious Explosions

Kepler Solves Mystery of Fast and Furious Explosions

Space Observatory Captures the Details of an Unusual Stellar Detonation

The universe is full of mysterious exploding phenomena that go boom in the dark. One particular type of ephemeral event, called a Fast-Evolving Luminous Transient (FELT), has bewildered astronomers for a decade because of its very brief duration. Now, NASA’s Kepler Space Telescope—designed to go hunting for planets across our galaxy—has also been used to catch FELTs in the act and determine their nature. They appear to be a new kind of supernova that gets a brief turbo boost in brightness from its surroundings.

Kepler’s ability to precisely sample sudden changes in starlight has allowed astronomers to quickly arrive at this model for explaining FELTs, and rule out alternative explanations...

Read More

Study suggests method to Boost Growth of Blood Vessels and Muscle

An MIT-led research team reversed age-related endurance loss in mice by treating them with a compound that promotes new blood vessel growth.

An MIT-led research team reversed age-related endurance loss in mice by treating them with a compound that promotes new blood vessel growth.

Activating proteins linked to longevity may help to increase endurance and combat frailty in the elderly. As we get older, our endurance declines, in part because our blood vessels lose some of their capacity to deliver oxygen and nutrients to muscle tissue. An MIT-led research team has now found that it can reverse this age-related endurance loss in mice by treating them with a compound that promotes new blood vessel growth. The compound, which re-activates longevity-linked proteins called sirtuins, promotes the growth of blood vessels and muscle, boosting the endurance of elderly mice by up to 80%.

If the findings translate to humans, this restorati...

Read More